Short Interest in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Decreases By 65.0%

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) saw a significant decline in short interest during the month of February. As of February 27th, there was short interest totaling 5,366 shares, a decline of 65.0% from the February 12th total of 15,313 shares. Currently, 0.1% of the company’s stock are sold short. Based on an average daily trading volume, of 20,956 shares, the short-interest ratio is currently 0.3 days. Based on an average daily trading volume, of 20,956 shares, the short-interest ratio is currently 0.3 days. Currently, 0.1% of the company’s stock are sold short.

Institutional Trading of Invesco Pharmaceuticals ETF

Several institutional investors have recently made changes to their positions in PJP. Northwestern Mutual Wealth Management Co. lifted its position in shares of Invesco Pharmaceuticals ETF by 829.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 25,941 shares of the company’s stock worth $2,712,000 after buying an additional 23,150 shares in the last quarter. Wells Fargo & Company MN grew its holdings in shares of Invesco Pharmaceuticals ETF by 96.8% in the fourth quarter. Wells Fargo & Company MN now owns 37,772 shares of the company’s stock valued at $3,949,000 after acquiring an additional 18,576 shares in the last quarter. BNP Paribas Financial Markets bought a new position in shares of Invesco Pharmaceuticals ETF in the second quarter valued at approximately $799,000. Ameriprise Financial Inc. increased its position in shares of Invesco Pharmaceuticals ETF by 214.4% during the third quarter. Ameriprise Financial Inc. now owns 12,236 shares of the company’s stock valued at $1,114,000 after acquiring an additional 8,344 shares during the last quarter. Finally, Gilpin Wealth Management LLC purchased a new stake in shares of Invesco Pharmaceuticals ETF during the fourth quarter valued at approximately $735,000.

Invesco Pharmaceuticals ETF Trading Up 0.2%

Shares of Invesco Pharmaceuticals ETF stock opened at $106.08 on Wednesday. The company has a market capitalization of $405.23 million, a P/E ratio of 15.59 and a beta of 0.50. The stock has a fifty day simple moving average of $106.78 and a 200 day simple moving average of $101.17. Invesco Pharmaceuticals ETF has a 12-month low of $72.25 and a 12-month high of $110.81.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.